The Cancer Genome Atlas output and practice of gastric cancer

Any clinical professionals who devote themselves to prevention, diagnosis, therapy, and management of gastric cancer patients are now again facing another achievement by the consortium of The Cancer Genome Atlas (TCGA) (1). In the era of post human genome sequence and massive parallel sequencing technology, every week this kind of huge data draw a transient attention of our colleagues who are very busy with conventional routines. Information like this on the cutting edge of science is not usually related to the action plan next week at the clinic. In a field of lung cancer managements, however, we witnessed the latest fruits of these technologies such as series of discoveries of targetable fused-kinase protein drastically changed clinical practice (2)